MCK McKesson

  • Official Name: MCKESSON CORPORATION
  • Headquarters: 6555 State Highway 161, IRVING, TX, 75039 US
  • CEO: Brian S. Tyler
  • Website: mckesson.com

Match Results

Date League Week Opponent Result Score
2025-07-18 1 Won by 5.560 1.450 - (4.110)
2025-07-25 2 Lost by 5.699 1.593 - 7.292
2025-07-29 2R Won by 3.968 1.601 - (2.367)
2025-08-01 3 Lost by 0.212 (1.133) - (0.921)
2025-08-06 1R Lost by 0.961 (0.203) - 0.758
2025-08-07 1R Lost by 6.629 (3.587) - 3.042
2025-08-08 4 Lost by 4.724 (1.369) - 3.355
2025-08-12 3R Lost by 2.886 (1.784) - 1.102
2025-08-15 5 Lost by 1.358 2.976 - 4.334
2025-08-22 6 Lost by 0.556 3.300 - 3.856
2025-08-29 7 Lost by 2.191 (0.300) - 1.891
2025-09-05 8 Won by 1.625 0.079 - (1.546)
2025-09-12 9 Won by 4.482 TOTW 3.887 - (0.595)
2025-09-19 10 Won by 1.720 (2.131) - (3.851)
2025-09-26 11 Lost by 2.383 7.659 - 10.042
2025-10-03 12 Won by 1.354 (3.103) - (4.457)
2025-10-10 13 Won by 2.604 TOTW 3.492 - 0.888
2025-10-17 14 Won by 4.367 2.969 - (1.398)
2025-10-24 15 Lost by 3.710 1.962 - 5.672

Latest News

Coca-Cola, Visa and Mastercard Hit Records as Investors Rotate Out of Chip Stocks
Yahoo - 2026-10-16

Coca-Cola, Visa and Mastercard Hit Records as Investors Rotate Out of Chip Stocks 🔗

Coca-Cola, Visa and Mastercard are among the stocks hitting records as investors look beyond the AI trade. Earnings could help broaden the rally.

Blue Shield of California Appoints Seasoned Financial Leader Erin Brewer to Board of Directors
Yahoo - 2026-10-15

Blue Shield of California Appoints Seasoned Financial Leader Erin Brewer to Board of Directors 🔗

Blue Shield of California today announced the appointment of Erin Brewer, strategic advisor, and former chief financial officer at Lyft, to its Board ...

AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo - 2026-10-15

AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? 🔗

AbbVie is raising its outlook with Skyrizi and Rinvoq offsetting Humira losses. Pfizer is rebuilding its pipeline around obesity drugs and key readout...

Jim Cramer: This Health Care Stock Is A ‘Winner’, X-Energy Is ‘Losing Too Much Money’
Benzinga - 2026-10-15

Jim Cramer: This Health Care Stock Is A ‘Winner’, X-Energy Is ‘Losing Too Much Money’ 🔗

Cramer favors McKesson and Medtronic, while avoiding X-Energy and Cipher; he says Vishay is overpriced and advises waiting for a dip.

McKesson (MCK) Ascends While Market Falls: Some Facts to Note
Yahoo - 2026-10-14

McKesson (MCK) Ascends While Market Falls: Some Facts to Note 🔗

McKesson (MCK) reached $976.57 at the closing of the latest trading day, reflecting a +1.53% change compared to its last close.

Lightning Round: Cipher is going down because it should be going down, says Jim Cramer
CNBC - 2026-10-14

Lightning Round: Cipher is going down because it should be going down, says Jim Cramer 🔗

'Mad Money' host Jim Cramer weighs in on stocks including: X-Energy, McKesson, Cipher, and more.

3 Large-Cap Stocks to Keep an Eye On
Yahoo - 2026-10-13

3 Large-Cap Stocks to Keep an Eye On 🔗

Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding ...

McKesson: Re-Rated Again Amidst Increased M&A Efforts
SeekingAlpha - 2026-10-12

McKesson: Re-Rated Again Amidst Increased M&A Efforts 🔗

McKesson stock is up 170% since 2022. Learn what’s driving growth, how recent M&A reshapes its portfolio, and if valuation limits upside.

AbbVie vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo - 2026-10-12

AbbVie vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026? 🔗

AbbVie trades at a 40% valuation discount but faces revenue concentration risk, while Eli Lilly's cardiometabolic dominance commands a premium.

McKesson (MCK) Stock Could Be 43% Undervalued Despite Its $1.4B Infusion Deal
Yahoo - 2026-10-12

McKesson (MCK) Stock Could Be 43% Undervalued Despite Its $1.4B Infusion Deal 🔗

McKesson has been a powerful long term winner. With the share price now at US$938.84, the real question is whether the business can keep generating ca...

McKesson (MCK) Extends CVS Deal, Is The Stock Fully Valued?
Yahoo - 2026-10-12

McKesson (MCK) Extends CVS Deal, Is The Stock Fully Valued? 🔗

McKesson (MCK) shares are in focus after the distributor reached an agreement in principle to extend its pharmaceutical distribution partnership with ...

Does New CVS and EPIC Deals Reshape McKesson’s Pharmacy Distribution Narrative (MCK)?
Yahoo - 2026-10-12

Does New CVS and EPIC Deals Reshape McKesson’s Pharmacy Distribution Narrative (MCK)? 🔗

In October 2026, EPIC Pharmacies introduced a new wholesale distribution model naming McKesson as one of two primary partners, while McKesson separate...

Show more